Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.22) by 25.56 percent. This is a 27.27 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $11.282 million which missed the analyst consensus estimate of $11.350 million by 0.60 percent. This is a 37.28 percent increase over sales of $8.218 million the same period last year.